Lilly, Roche Drugs Chosen for Alzheimer Prevention Trial

Alzheimer’s drugs from Eli Lilly & Co. and Roche Holding AG were selected for a long-term study that, if successful, may lead to the treatments being used as a deterrent for people with a family history of the disease.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.